Evidence map›Paper›PMID 24681654›Full record

ArticleInflammatory bowel diseases2014

Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment.

Maggie Ham, Maria S Longhi, Conor Lahiff, Adam Cheifetz, Simon Robson, Alan C Moss

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis.Calcified tissue international · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maggie HamDivision of Gastroenterology, Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Maria S Longhi
Conor Lahiff
Adam Cheifetz
Simon Robson
Alan C Moss
Beth Israel Deaconess Medical Center · US

Funding

Purinergic Pathways in Crohn's DiseaseK23DK084338 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MOSS, ALAN COLM · 2011 to 2015
$735k
Medical Research Council G0902288Medical Research Council MR/J006742/1NIDDK NIH HHS K23 DK084338NIDDK NIH HHS K23DK084338
6 · The paper itself

Abstract

backgroundVitamin D deficiency is common in patients with Crohn's disease (CD), although whether this impairs immune responsiveness, and is related to disease activity per se, remains unclear. We sought to investigate vitamin D pathways in patients with CD according to measures of inflammation and immune response.

methodsProspectively collected samples of a well-characterized cohort of patients with CD were used to measure serum 25(OH)-vitamin D levels by enzyme-linked immunoassay. Related gene expression was determined by polymerase chain reaction in T cells. The effect of vitamin D on the proliferation of isolated CD4 cells was determined.

resultsPatients with active CD had lower serum vitamin D levels than those in clinical remission; this measurement was independent of season or reported use of vitamin D supplements. Harvey-Bradshaw Index scores, but not C-reactive protein, correlated with serum vitamin D levels. Gene expression of the vitamin D receptor was higher in peripheral blood T cells from patients with active disease than in those in remission. The proportion of CD25hi CD4 cells from patients with CD increased in the presence of vitamin D. After treatment with infliximab, significant increases in serum vitamin D levels were noted in patients.

conclusionsLow vitamin D levels are associated with disease activity in CD and increase after infliximab treatment.

Indexed as

AdultAntibodies, MonoclonalAnti-Inflammatory Agents, Non-SteroidalCD4-Positive T-LymphocytesCell ProliferationC-Reactive ProteinCrohn DiseaseDietary SupplementsEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryFollow-Up StudiesHumansInfliximabMalePrognosisAntibodies, MonoclonalAnti-Inflammatory Agents, Non-SteroidalC-Reactive ProteinInfliximabVitamin D

Identifiers

PMID24681654
PMCPMC4077052
OpenAlexW2032501249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.